Copyright
©The Author(s) 2017.
World J Gastroenterol. Jan 7, 2017; 23(1): 11-24
Published online Jan 7, 2017. doi: 10.3748/wjg.v23.i1.11
Published online Jan 7, 2017. doi: 10.3748/wjg.v23.i1.11
Table 1 Causes of fecal incontinence
| Category | Details |
| Acquired structural abnormalities | Obstetric injury (vaginal delivery) |
| Anorectal surgery (hemorrhoid, fistula, fissure, etc.) | |
| Rectal intussusception/prolapse | |
| Sphincter-sparing bowel resection | |
| Trauma (e.g., pelvic fracture, Anal impalement) | |
| Functional disorders | Chronic diarrhea |
| Irritable bowel disease | |
| Inflammatory bowel disease | |
| Radiation proctitis | |
| Malabsorption | |
| Hypersecretory tumors | |
| Fecal impaction (paradoxical diarrhea) | |
| Physical disabilities | |
| Psychiatric disorder | |
| Neurological disorders | Pudendal neuropathy |
| (radiation, diabetes, chemotherapy) | |
| Spinal surgery | |
| Multiple sclerosis | |
| Dementia | |
| CNS disorder: stroke, trauma, tumor, infection | |
| Spina bifida | |
| Congenital disorders | Imperforate anus |
| Cloacal defect | |
| Spina bifida (myelomeningocele, meningocele) |
Table 2 Cleveland Clinic Fecal Incontinence Score[12]
| Parameter | Frequency | ||||
| Never | Rarely | Sometimes | Usually | Always | |
| (< 1/mo) | (< 1/wk but ≥ 1/mo) | (< 1/d but ≥ 1/wk) | (≥ 1/d) | ||
| Incontinence to solid stool | 0 | 1 | 2 | 3 | 4 |
| Incontinence to liquid/loose stool | 0 | 1 | 2 | 3 | 4 |
| Incontinence to gas | 0 | 1 | 2 | 3 | 4 |
| Wears pad | 0 | 1 | 2 | 3 | 4 |
| Lifestyle alteration | 0 | 1 | 2 | 3 | 4 |
Table 3 Structured workup of patients with fecal incontinence
| Assessment tool | Details |
| History | Onset |
| Quantitation: staining < soilage < seepage < accidents | |
| Qualitative assessment: passive incontinence vs urge incontinence | |
| Obstetrical history: pregnancies, vaginal deliveries | |
| Previous surgeries: anorectal surgeries, hysterectomy, bladder surgeries, (colo)rectal surgeries, spinal surgeries | |
| Underlying diseases (diabetes, stroke, etc.) | |
| Bowel function and stool quality | |
| Incomplete evacuation | |
| Stool/gas passage through vagina | |
| Medications | |
| Scoring instruments | CCF incontinence score (“Wexner score”) |
| Fecal Incontinence Quality of Life score | |
| Fecal Incontinence Severity Index | |
| St. Marks Incontinence Score | |
| EORTEC SF-36 | |
| Revised Fecal Incontinence Scale | |
| Other scoring instruments | |
| Physical exam | Inspection: patulous anus, folds, perineal body, keyhole, skin irritation, perineal descent, prolapse, cloaca, rectovaginal fistula (stool in vagina)? |
| Digital exam: sphincter integrity, tone (rest/squeeze), compensatory contraction/discoordination, rectocele, mass? | |
| Sensation/anal reflex | |
| Instrumentation/visualization: rule out other pathologies (e.g., rectal tumor, proctitis) | |
| Anophysiology testing | Anal ultrasound |
| Anophysiology testing: | |
| Manometry | |
| Anorectal sensation and volume tolerance | |
| Compliance measurement | |
| Nerve studies: PNTML, occasionally EMG | |
| Placement of SNS trial electrode (phase I) | |
| Additional evaluations in select cases | Imaging: dynamic pelvic MRI |
| Defecating proctogram | |
| Evaluation by other specialties (Urogynecology, Urology, Gastroenterology, etc.) |
Table 4 Surgical strategies
| Goal | Options |
| Correction of morphological deformities | Prolapse |
| Cloaca | |
| Keyhole deformity | |
| Perirectal fistula | |
| Rectovaginal fistula | |
| Tumor | |
| Sphincter repair | Overlapping sphincteroplasty |
| Enhancement of impaired sphincter function | Sacral nerve stimulation |
| Radiofrequency energy administration (SECCA™) | |
| Injection of bulking agents (NASHA/DX, beads etc.) | |
| Sphincter replacement/support | Artificial bowel sphincter |
| Implantation of magnetic anal sphincter (Fenix™) | |
| Graciloplasty | |
| Implantation of Thiersch | |
| Implantation of pelvic sling system | |
| Diversion | Colostomy |
| Reduction of fecal load | Malone antegrade continence enema |
Table 5 Types of injectable/implantable materials
| Category | Details |
| Conventional | Carbon |
| Teflon or silicon biomaterial beads | |
| Collagen | |
| Autologous fat | |
| Newer | Non-animal stabilized hyaluronic acid/dextranomer |
| Pilot | Self-expandable hyexpan (polyacrylonitrile) prosthesis |
| Future | Stem cells |
Table 6 Overview of various surgical options with respective outcomes (as detailed in the text)
| Interventions category | Specific technique | Efficacy rate (complete/> 50% improvement) | Complication rates | Grade |
| Correction of morphological abnormalities | Depending on underlying condition: | N/A | N/A | N/A |
| Prolapse, cloaca, keyhole deformity, perirectal fistula, rectovaginal fistula, tumor | ||||
| Sphincter repair | Overlapping sphincteroplasty | 75%-85% (short term) | N/A | |
| 0-50% (after 5-10 yr) | ||||
| Enhancement of sphincter function | Sacral nerve stimulation | 0%-56%/51-100% | lead displacement (15%), diarrhea (6%), pain (6-28%), bleeding 11%, infection (3%) | 1B |
| Tibial nerve simulation | 0%-12% (-40%)/0%-67% | 59% (infection, mild gastrodynia, temporary leg numbness) | 2C | |
| Radiofrequency energy administration | 0%/12%-38% (-84%) | 0%-52% (pain, bleeding, infection) | 2B | |
| Injection of: | 0%/33%-90% | 10%-12% (pain, bleeding, infection) | 2A | |
| conventional bulking agents | 6%/56%-61% | |||
| NASHA/DX | ||||
| Sphincter replacement | Artificial bowel sphincter | 61%-90%/31%-100% | 5%-10% infection rates, 30%-52% long-term failure 9 | 1B |
| Implantation of magnetic ring (Fenix™) | NA/54% | 0%-7% obstruction, infection, erosion | 1C | |
| Graciloplasty (dynamic/non-dynamic) | NA/72% | > 40% including urinary tract infection/retention, infections 76 | 2C | |
| Implantation of Thiersch | N/A | N/A | N/A | |
| Pelvic floor repairs/sling | 19%/69.1% | 17%-30% (pain, infection) | 2C | |
| Fecal diversion | Ileostomy, loop colostomy, end colostomy | near 100% FI improvement | 5%-10% stoma outlet obstruction, stricture, prolapse, hernia | 1C |
| Fecal load reduction | Malone antegrade continence enema | (0%)/33%-100% FI continence | 8%-50% stoma stenosis, leakage | 2C |
- Citation: Saldana Ruiz N, Kaiser AM. Fecal incontinence - Challenges and solutions. World J Gastroenterol 2017; 23(1): 11-24
- URL: https://www.wjgnet.com/1007-9327/full/v23/i1/11.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i1.11
